ArticleHealth science reports2026
Evaluation of Prevalence and Risk Factors of Possible Sarcopenia Based on SARC-F in Adults Over 60 in Tegucigalpa, Honduras: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Benchmarking Interpretable Machine Learning for Frailty Screening in Older Adults Using Routine Clinical Variables with and Without SARC-F: A Pilot Diagnostic Study.Diagnostics (Basel, Switzerland) · 2026Article
- Evaluation of Prevalence and Risk Factors of Possible Sarcopenia Based on SARC-F in Adults Over 60 in Tegucigalpa, Honduras: A Cross-Sectional Study.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Sarcopenia, a progressive loss of skeletal muscle mass and function, poses a growing public health challenge in low and middle-income settings. We aimed to quantify its prevalence and identify sex-specific risk factors among older adults attending a public outpatient clinic in Tegucigalpa, Honduras. Methods: In a hospital-based, age-stratified random sample, we enrolled 100 participants (73 women and 27 men; mean age = 69.7 ± 6.9 years) during July 2024. Possible sarcopenia and frailty were assessed using SARC-F and FRAIL questionnaires, respectively. Body mass index was calculated under standardized conditions and mean arterial pressure (MAP) was derived from blood pressure measurements. Normality of continuous variables was evaluated with the Shapiro-Wilk test. Between-sex differences were analyzed using Welch's Results: Possible sarcopenia (SARC‑F ≥ 4) was present in 48% of participants (95% CI = 38-58), while 40% met criteria for frailty. Women showed a significantly higher mean BMI than men (28.0 ± 5.7 kg m Conclusions: Nearly half of older adults were at risk of sarcopenia and two-fifths were frail, with women more affected. Elevated blood pressure was linked to functional decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.